XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
EXICURE, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.03−0.09 (-8.04%)
Close on Oct 19, 2026
- Market cap
- $6.57M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
2.1%
0M of 7M shares
Institutional holders
17
3 new, 4 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 4 sales
Net sold $11.58M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| DGP Co., Ltd. | 849,223 | 39.10% | 13D (active) amendment | Sep 12, 2024 |
| Junwon Yoo | 433,332 | 14.30% | 13G (passive) | Dec 12, 2024 |
| HiTron Systems Inc. | 3,333,333 | 52.80% | 13D (active) amendment | Dec 26, 2024 |
| Exicure HiTron Inc. | 2,222,224 | 34.90% | 13D (active) amendment | Jul 8, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of XCUR | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 43,111 | 0.66% | $89.67K | +10,128 | 0.00% |
| Geode Capital Management, LLC | 31,249 | 0.48% | $65.01K | −5,664 | 0.00% |
| Jane Street Group, LLC | 29,535 | 0.45% | $61.43K | New | 0.00% |
| Citadel Advisors LLC | 14,919 | 0.23% | $31.03K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 13,161 | 0.20% | $27.38K | – | 0.00% |
| Tower Research Capital LLC (TRC) | 4,074 | 0.06% | $8.47K | +3,585 | 0.00% |
| UBS Group AG | 342 | 0.01% | $711 | −524 | 0.00% |
| Morgan Stanley | 143 | 0.00% | $297 | −15 | 0.00% |
| Royal Bank of Canada | 82 | 0.00% | $0 | New | 0.00% |
| SBI Securities Co., Ltd. | 43 | 0.00% | $89 | – | 0.00% |
| BlackRock, Inc. | 35 | 0.00% | $73 | −9,318 | 0.00% |
| Osaic Holdings, Inc. | 29 | 0.00% | $60 | – | 0.00% |
| Prestige Wealth Management Group LLC | 20 | 0.00% | $42 | – | 0.00% |
| Harbour Investments, Inc. | 17 | 0.00% | $35 | – | 0.00% |
| Caitong International Asset Management Co., Ltd | 6 | 0.00% | $12 | +5 | 0.00% |
| Bnp Paribas Arbitrage, Snc | 4 | 0.00% | $8 | – | 0.00% |
| JPMorgan Chase & Co | 2 | 0.00% | $4 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 17 | 0M | 2.1% | 3 / 3 | 4 / 4 | 0M | 0M |
| Q1 2026 | 18 | 0M | 2.5% | 6 / 3 | 2 / 2 | 0M | 0M |
| Q4 2025 | 15 | 0M | 2.3% | 3 / 2 | 6 / 0 | 0M | 0M |
| Q3 2025 | 12 | 0M | 5.8% | 0 / 7 | 2 / 2 | 0M | 0M |
| Q2 2025 | 14 | 0M | 5.7% | 2 / 4 | 3 / 0 | 0M | 0M |
| Q1 2025 | 12 | 0M | 4.9% | 1 / 4 | 3 / 0 | 0M | 0M |
| Q4 2024 | 11 | 0M | 4.5% | 2 / 2 | 5 / 2 | 0M | 0M |
| Q3 2024 | 11 | 0M | 1.3% | 11 / 0 | 0 / 0 | 0M | 0M |
| Q2 2021 | 0 | 0M | 0.0% | 0 / 0 | 0 / 1 | 0M | 0M |
| Q1 2021 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q4 2020 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
| Q3 2020 | 1 | 0M | 0.0% | 0 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of XCUR | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 28,883 | 0.44% | $60.08K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 19,367 | 0.30% | $61.97K | 0.00% | May 31, 2026 |
| Vanguard Total Stock Market Index Fund | 14,228 | 0.22% | $29.59K | 0.00% | Jun 30, 2026 |
| Fidelity Total Market Index Fund | 4,731 | 0.07% | $15.14K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 3,639 | 0.06% | $11.64K | 0.00% | May 31, 2026 |
| Fidelity Nasdaq Composite Index Fund | 2,912 | 0.04% | $9.32K | 0.00% | May 31, 2026 |
| Diversified Equity Alpha Master Portfolio | 35 | 0.00% | $73 | 0.00% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Andy Yoo | Chief Restructuring Officer, Director | 73,666 | 1.13% | Nov 26, 2024 |
| Josh Miller | Chief Accounting Officer | 301 | 0.00% | Feb 19, 2026 |
| Sangjin Yeo | Director | – | – | Sep 29, 2025 |
| Aejin Hwang | Director | – | – | Sep 29, 2025 |
| Min Woo Kang | Director | – | – | Mar 24, 2025 |
| Ho Jung John | Director | – | – | Mar 24, 2025 |
| Chang Keun Choi | Director | – | – | Mar 24, 2025 |
| Sang Wook Song | Director | – | – | Mar 24, 2025 |
| Seung Ik Baik | Director | – | – | Nov 26, 2024 |
| HiTron Inc. Exicure | 10% owner | 2,222,224 | 33.95% | Jul 17, 2026 |
| Sangsangin Investment & Securities Co., Ltd. | 10% owner | 0 | – | Dec 10, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| HiTron Inc. Exicure 10% owner | Jul 8, 2026 | Other | +117,441 | $4.50 | $528.48K | 2,222,224 |
| HiTron Inc. Exicure 10% owner | Jun 26, 2026 | Other | +253,195 | $4.50 | $1.14M | 2,104,781 |
| HiTron Inc. Exicure 10% owner | Jun 24, 2026 | Other | +123,456 | $4.50 | $555.55K | 1,851,586 |
| HiTron Inc. Exicure 10% owner | Jun 23, 2026 | Other | +129,183 | $4.50 | $581.32K | 1,728,130 |
| Josh Miller Chief Accounting Officer | Feb 16, 2026 | Tax withholding | −8 | $4.08 | $33 | 301 |
| HiTron Inc. Exicure 10% owner | Jan 21, 2026 | Sale | −258,367 | $4.50 | $1.16M | 1,598,947 |
| HiTron Inc. Exicure 10% owner | Jan 16, 2026 | Sale | −734,747 | $4.50 | $3.31M | 1,857,314 |
| HiTron Inc. Exicure 10% owner | Jan 7, 2026 | Sale | −741,272 | $4.50 | $3.34M | 2,592,061 |
| Sangsangin Investment & Securities Co., Ltd. 10% owner | Dec 8, 2025 | Sale | −433,332 | $8.71 | $3.77M | 0 |
| Josh Miller Chief Accounting Officer | Nov 16, 2025 | Tax withholding | −7 | $3.71 | $26 | 309 |
| Josh Miller Chief Accounting Officer | Aug 16, 2025 | Tax withholding | −9 | $6.65 | $60 | 316 |
| Josh Miller Chief Accounting Officer | May 16, 2025 | Tax withholding | −8 | $10.06 | $80 | 325 |
| Josh Miller Chief Accounting Officer | Feb 16, 2025 | Tax withholding | −9 | $10.03 | $90 | 333 |
| HiTron Inc. Exicure 10% owner | Dec 26, 2024 | Buy | +2,900,000 | $3.00 | $8.70M | 3,333,333 |
| Josh Miller Chief Accounting Officer | Nov 16, 2024 | Tax withholding | −7 | $2.90 | $20 | 342 |
| DGP Co., Ltd. 10% owner | Sep 12, 2024 | Buy | +237,223 | $3.00 | $711.67K | 849,223 |
| Josh Miller Chief Accounting Officer | Aug 16, 2024 | Tax withholding | −38 | $0.36 | $14 | 1,743 |
| Josh Miller Chief Accounting Officer | May 16, 2024 | Tax withholding | −46 | $0.52 | $24 | 1,781 |
| DGP Co., Ltd. 10% owner | Feb 29, 2024 | Sale | −3,400,000 | $1.32 | $4.49M | 0 |
| Josh Miller Chief Accounting Officer | Feb 16, 2024 | Tax withholding | −46 | $0.60 | $28 | 1,827 |
| Josh Miller Chief Accounting Officer | Nov 16, 2023 | Tax withholding | −38 | $0.57 | $22 | 1,873 |
| Josh Miller Chief Accounting Officer | Aug 16, 2023 | Tax withholding | −37 | $0.83 | $31 | 1,911 |
| CBI USA, Inc. 10% owner | Jun 23, 2023 | Conversion | −3,400,000 | $1.60 | $5.44M | 818,299 |
| Josh Miller Chief Accounting Officer | May 16, 2023 | Tax withholding | −185 | $1.07 | $198 | 1,948 |
| CBI USA, Inc. 10% owner | Dec 15, 2022 | Buy | +3,400,000 | $1.60 | $5.44M | 4,218,299 |
| Bali Muralidhar Director | May 19, 2022 | Buy | +1,472,126 | $0.19 | $279.70K | 8,449,126 |
| William H. Gates Iii 10% owner | Dec 21, 2021 | Sale | −1,268,619 | $0.24 | $304.47K | 5,064,703 |
| David A. Giljohann Chief Executive Officer, Director | Nov 15, 2021 | Award | +7,500 | $0.91 | $6.83K | 38,666 |
| Douglas E. Feltner Chief Medical Officer | Nov 15, 2021 | Award | +7,500 | $0.91 | $6.83K | 15,000 |
| Elias D. Papadimas Chief Accounting Officer | Aug 27, 2021 | Buy | +10,000 | $1.38 | $13.80K | 10,000 |
| David A. Giljohann Chief Executive Officer, Director | May 14, 2021 | Award | +7,500 | $1.27 | $9.53K | 31,166 |
| Matthias Schroff Chief Operating Officer | May 14, 2021 | Award | +7,500 | $1.27 | $9.53K | 7,500 |
| Douglas E. Feltner Chief Medical Officer | May 14, 2021 | Award | +7,500 | $1.27 | $9.53K | 7,500 |
| Jay Venkatesan Director | Jul 6, 2020 | Option exercise | +9,310 | $0.65 | $6.05K | 311,544 |
| Jay Venkatesan Director | Jul 6, 2020 | Option exercise | +12,930 | $1.03 | $13.32K | 324,473 |
| Llc Aurasense 10% owner | Jun 12, 2020 | Sale | −10,195 | $2.83 | $28.85K | 11,257,629 |
| Chad A. Mirkin Director, 10% owner | Jun 12, 2020 | Sale | −10,195 | $2.83 | $28.85K | 11,257,629 |
| Chad A. Mirkin Director, 10% owner | May 20, 2020 | Option exercise | +49,649 | $0.65 | $32.27K | 64,649 |
| David R. Walt Director | Mar 13, 2020 | Buy | +291,066 | $1.21 | $352.19K | 2,058,777 |
| Chad A. Mirkin Director, 10% owner | Mar 12, 2020 | Buy | +15,000 | $1.45 | $21.75K | 15,000 |
| David S. Snyder Chief Financial Officer | Mar 12, 2020 | Buy | +18,248 | $1.40 | $25.55K | 18,248 |
| Bali Muralidhar Director | Dec 19, 2019 | Buy | +727,000 | $2.75 | $2.00M | 6,977,000 |
| Jay Venkatesan Director | Aug 2, 2019 | Buy | +250,000 | $2.00 | $500.00K | 302,234 |
| Chad A. Mirkin Director, 10% owner | Aug 2, 2019 | Buy | +25,000 | $2.00 | $50.00K | 25,000 |
| David R. Walt Director | Aug 2, 2019 | Buy | +1,000,000 | $2.00 | $2.00M | 1,767,711 |
| Chad A. Mirkin Director, 10% owner | Mar 22, 2019 | Buy | +500 | $2.30 | $1.15K | 27,267 |
| Chad A. Mirkin Director, 10% owner | Mar 21, 2019 | Buy | +1,000 | $2.43 | $2.43K | 26,767 |
| David A. Giljohann Chief Executive Officer, Director | Mar 19, 2019 | Buy | +7,000 | $2.40 | $16.80K | 23,666 |
| Chad A. Mirkin Director, 10% owner | Mar 18, 2019 | Buy | +1,000 | $2.40 | $2.40K | 25,767 |
| Chad A. Mirkin Director, 10% owner | Mar 13, 2019 | Buy | +2,200 | $2.50 | $5.50K | 24,767 |
| David R. Walt Director | Sep 26, 2017 | Award | +499,378 | – | – | 499,378 |
| David R. Walt Director | Sep 26, 2017 | Buy | +268,333 | $3.00 | $805.00K | 767,711 |
| Chad A. Mirkin Director, 10% owner | Sep 26, 2017 | Other | +6,669 | – | – | 6,669 |
| Chad A. Mirkin Director, 10% owner | Sep 26, 2017 | Award | +22,567 | – | – | 22,567 |
| Chad A. Mirkin Director, 10% owner | Sep 26, 2017 | Other | +11,267,824 | – | – | 11,267,824 |
| Jay Venkatesan Director | Sep 26, 2017 | Other | +90,192 | – | – | 90,192 |
| Jay Venkatesan Director | Sep 26, 2017 | Award | +52,234 | – | – | 52,234 |
| Jay Venkatesan Director | Sep 26, 2017 | Buy | +66,666 | $3.00 | $200.00K | 156,858 |
| Jay Venkatesan Director | Sep 26, 2017 | Other | +190,957 | – | – | 190,957 |
| Mark N. Tompkins – | Sep 26, 2017 | Buy | +166,667 | $3.00 | $500.00K | 1,825,667 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.